HL-8

CAT: 0804-HY-143275-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-143275-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
HL-8 is a PI3Kα PROTAC degrader. HL-8 promotes the ubiquitination and degradation of PI3Kα. HL-8 reduces pAKT levels. HL-8 has anticancer activity against colon and cervical cancer (Pink: PI3Kα ligand (HY-143277) ; Blue: E3 ligase VHL ligand (HY-138678) ; Black: linker (HY-W002042) ) [1].
CAS Number
[2766352-64-9]
UNSPSC
12352005
Target
Akt; PI3K; PROTACs
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hl-8.html
Purity
99.17
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=NC=C(C=C1NS(=O)(C2=C(C=C(C=C2)F)F)=O)C3=CN4C(C5=NN=C(O5)C6=C(C=CC=C6)C(NCCCCCCC(N[C@@H](C(C)(C)C)C(N7C[C@H](C[C@@H]7C(NCC8=CC=C(C=C8)C9=C(N=CS9)C)=O)O)=O)=O)=O)=CN=C4C=C3
Molecular Formula
C57H59F2N11O9S2
Molecular Weight
1144.27
References & Citations
[1]Wang H, et al. Design, synthesis and activity study of a novel PI3K degradation by hijacking VHL E3 ubiquitin ligase. Bioorg Med Chem. 2022 May 1;61:116707.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-142533HL-PEG2k
HY-143277HL-2
HY-160956Nitto Phase HL UnyLinker 300
HY-161737-01YT-8-8
HY-160589Nav1.8-IN-8
HY-N8842-018,8''-Bibaicalein
HY-N136418,8''-Biskoenigine
HY-W032015S21-Bromooctane-8,8,8-d3
HY-D0062-01(-) -8,8-Dichlorocampherylsulfonyl-oxaziridine
HY-153543-01TLR7/8 agonist 8

Alternative Products

CatalogName
T74258-01HL-8
YP-W22585-01Mouse α-HL (α-HL) ELISA Kit
RWT-1028HL 60/ HL-60 Cell Line
ARC0298HL-60
T209595-01HL-2
E58P1088Serpin Hl
ARI0058HL-1
GZ3821-5000UHL-Nuclease
T208153-01HL-PEG2k
MBS9402811-01HL antibody

Popular Products